A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer

Annals of Surgery

Volumn 247, Issue 2, 2008, Pages 282-287

  Kattan, Michael W ^a   Gönen, Mithat ^b   Jarnagin, William R ^b   DeMatteo, Ronald ^b   D'Angelica, Michael ^b   Weiser, Martin ^b   Blumgart, Leslie H ^b   Fong, Yuman ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BOOTSTRAPPING; CALIBRATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; POSTOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 38549162029     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31815ed67b     Document Type: Article

References (23)

1. Greene FL, American Joint Committee on Cancer. Liver (including intrahepatic bile ducts). In: AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002:131-138.
2. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566-571.
3. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189:291-299.
4. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262.
5. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318.
6. Mala T, Bohler G, Mathisen O, et al. Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg. 2002;26:1348-1353.
7. Jarnagin WR, Bodniewicz J, Dougherty E, et al. A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg. 2000;4:34-43.
8. Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 2002;235:392-399.
9. Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet. 1957;105:310-318.
10. Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247:2543-2546.
11. Harrell FEJ. S-plus software. In: Harrell FEJ, ed. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. 1st ed. New York: Springer-Verlag; 2001:105-120.
12. Nordlinger B, Parc R, Delva E, et al. Hepatic resection for colorectal liver metastases. Ann Surg. 1987;205:256-263.
13. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin. 1995;45:50-62.
14. Adam R, Lucidi V, Bismuth H. Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am. 2004;84:659-671.
15. Nicoli N, Casaril A, Mangiante G, et al. Surgical treatment for liver metastases from colorectal carcinoma: results of 228 patients. Hepatogastroenterology. 2004;51:1810-1814.
16. Wei AC, Greig PD, Grant D, et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol. 2006; Epub ahead of print.
17. Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable - does it work? Semin Oncol. 2005;32(6, Suppl 9):118-122.
18. Ferrone CR, Kattan MW, Tomlinson JS, et al. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23:7529-7535.
19. Shariat SF, Zippe C, Ludecke G, et al. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. J Urol. 2005;173:1518-1525.
20. Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13:111-116.
21. Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol. 2002;20:82-88.
22. Rouzier R, Pusztai L, Delaloge S, et al. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol. 2005;23:8331-8339.
23. Eastham JA, Kelly WK, Grossfeld GD, et al. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology. 2003;62(Suppl 1):55-62.